Raised serum CEA and CA 19-9 in Lung Cancer in tertiary care hospital in Eastern India
Journal Title: Journal of Medical Science And clinical Research - Year 2017, Vol 5, Issue 5
Abstract
Background: Lung cancer is the leading cause of cancer death worldwide. Unfortunately, most lung cancers are already unresectable and metastatic at initial diagnosis. Measurement of tumor markers is a noninvasive means to predict prognosis, and is therefore used in daily clinical practice. Aims & Objectives: The aim of this study was to assess the diagnostic yield of the tumour markers carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9, in serum and bronchoalveolar lavage fluid in a group of patients with bronchogenic carcinoma. Materials and Methods: Serum and bronchoalveolar lavage fluid samples were collected in a group of 38 cases with benign or malignant pulmonary diseases and 36 controls. The serum from all the subjects were analyzed for estimation of levels of various tumour markers like CEA and CA 19-9 using enzyme linked immunosorbant assay (ELISA) kits. Results: Serum CEA level was found significantly higher among lung cancer subjects with respect to controls (28.15 ± 8.11 versus 5.82 ± 2.66 µg/L; P < 0.001). Moreover, serum CA 19-9 levels were elevated in lung cancer cases as compared to controls and were statistically significant (60.08 ± 17.14 versus 23.75 ± 10.58 U/ml; P < 0.001). Serum CEA level does not have any correlation with serum CA 19-9 (r = 0.175; P=0.322) level among lung cancer subjects as well as in controls (r = 0.075; P = 0.670). Conclusion: Carcinoembryonic antigen was the most relevant marker in bronchoalveolar lavage fluid. For the factors evaluated in this study, determination of carcinoembryonic antigen and carbohydrate antigen 19- 9 in bronchoalveolar lavage fluid were clinically more useful markers in comparison with serum, although the latter may also be helpful in certain situations. Although there is no specific tumour marker for lung cancer, the combination of several can be used to diagnose most patients with lung cancer and also to rule out false positive and negative cases
Authors and Affiliations
Dr. Sanjay Kothari
Keywords
Related Articles
- EP ID EP285547
- DOI -
- Views 76
- Downloads 0
To Study Awareness Level of Dysphagia and Role of Speech Language Pathologist in Dysphagia Assessment and Management among Nurses
Over the years nearly every SLP department in the hospital across India has experienced a condition that poor referral from the medical professional for dysphagia management. This could be due to lack awareness among spe...
Study of Cord Blood Bilirubin Levels in a Tertiary Care Centre of Kumaun Region (Uttarakhand) India
Jaundice in newborn is a very common problem. Neonatal hyper bilirubinemia (NH) may lead to kernicterus in otherwise healthy newborns. This can be easily prevented if excessive hyper bilirubinemia for age is promptly ide...
Diagnostic Accuracy of FNAC in Evaluation of Breast Lumps
Background and objectives: This study was conducted to compare the diagnostic accuracy of fine needle aspiration cytology (FNAC)in differentiating the benign and malignant lesions of palpable breast lump with histopathol...
Study of Signs, Symptoms and Investigations of Congenital Heart Disease in A Teaching Hospital
Congenital heart disease one of the leading cause of morbidity and mortality in pediatric age group. The reported incidence is 8 per 1000 births. The reported incidence is 8 per 1000 births. Objective is to study the pat...
A Study of 50 Cases of Chest Injury in Trauma Patients
Introduction: Chest trauma constitutes 10-15% of all trauma patients and is cause of 25% of mortality. There are many vital organs in chest (heart, lung, major vessels, esophagus) that may injured due to trauma. Usually...